Gene · 10406
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnosis of ovarian cancer using multiple biomarkers of CA 125, CA153, CA 19-9, CEA, HE4 and ROMA index. | Ann Biol Clin (Paris) | 2026 | 42698297 | PubTator, text mining | PubMed |
| Design and Simulation of Ge Pocket Vertical TFET Biosensor for Label Free Detection of Ovarian Cancer Biomarker HE4. | IEEE Trans Nanobioscience | 2026 | 42678843 | PubTator, text mining | PubMed |
| HE4: a potential diagnostic biomarker in autoimmune diseases. | Cent Eur J Immunol | 2026 | 42677084 | PubTator, text mining | PubMed |
| Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study. | Cell Rep Med | 2026 | 42664958 | PubTator, text mining | PubMed |
| HE4 Silence Combined with DDP in the Treatment of Ovarian Cancer, Especially Platinum-resistant Ovarian Cancer. | Curr Cancer Drug Targets | 2026 | 42634368 | PubTator, text mining | PubMed |
| Integration of serological markers with O-RADS ultrasound risk stratification achieves high diagnostic accuracy for early ovarian cancer: development and validation of an interpretable model. | Am J Cancer Res | 2026 | 42597227 | PubTator, text mining | PubMed |
| A preoperative nomogram integrating transvaginal ultrasound endometrial thickness and nutritional, inflammatory, and metabolic indicators for predicting lymph node metastasis in endometrial cancer. | Front Public Health | 2026 | 42591223 | PubTator, text mining | PubMed |
| Discovery and Development of a TGFβ3/IL-13 Plasma Risk Score for Preoperative Discrimination of Benign and Malignant Ovarian Adnexal Masses. | Diagnostics (Basel) | 2026 | 42587603 | PubTator, text mining | PubMed |
| Low-Level Human Epididymis Protein 4 in Seminal Plasma Is an Independent Risk Factor for Poor Semen Liquefaction: A Case Control Study. | J Clin Lab Anal | 2026 | 42581555 | PubTator, text mining | PubMed |
| Application of Serum CA125, HE4, ROMA, and CPH-I in the Preoperative Differentiation of Ovarian Tumors: A Diagnostic Accuracy Study. | J Clin Lab Anal | 2026 | 42578276 | PubTator, text mining | PubMed |
| Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications. | Int J Gynecol Cancer | 2026 | 42542430 | PubTator, text mining | PubMed |
| Systems-Level Mapping of the Tumor Microenvironment Reveals Immune-Mediated Mechanisms and Potential Targets in Platinum-Resistant Ovarian Cancer. | Res Sq | 2026 | 42539139 | PubTator, text mining | PubMed |
| DNA Methylation and mRNA Expression of SEPT9 and AKR1B1 in Ovarian Cancer: Diagnostic and Prognostic Implications. | Int J Mol Sci | 2026 | 42511679 | PubTator, text mining | PubMed |
| Multi-Omics Profiling in a Symptomatic Cohort Identifies Coordinated Biomarker Signatures in Ovarian Cancer Serum. | Diagnostics (Basel) | 2026 | 42510006 | PubTator, text mining | PubMed |
| Development and validation of a blood biomarker risk prediction model for postmenopausal endometrioid endometrial cancer. | Front Endocrinol (Lausanne) | 2026 | 42490874 | PubTator, text mining | PubMed |
| [Medical prior-guided TabMap deep learning model for ovarian cancer prediction and interpretability analysis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | 42486839 | PubTator, text mining | PubMed |
| Diagnostic Value of O-RADS, CA125, and Ultra Microangiography in Differentiating Benign and Malignant Adnexal Masses: A Retrospective Analysis. | J Ultrasound Med | 2026 | 42464956 | PubTator, text mining | PubMed |
| Comparing and combining O-RADS ultrasound, serum CA125, and HE4 for the preoperative diagnosis of ovarian tumors. | BMC Med Imaging | 2026 | 42458283 | PubTator, text mining | PubMed |
| A Predictive Model for Major Adverse Aortic Events in Patients with Abdominal Aortic Aneurysm Using Clinical and Biomarker Data. | Int J Mol Sci | 2026 | 42450212 | PubTator, text mining | PubMed |
| Human epididymis protein 4: a potential prognostic biomarker for rheumatoid arthritis-associated interstitial lung disease. | Clin Rheumatol | 2026 | 42406253 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10406/papers?page=2